HEUKING advises MedTech start-up EVERSION on its Seed-II financing round

Ariane Neubauer, equity partner in HEUKING's Berlin office, provided comprehensive advice to EVERSION Technologies GmbH (EVERSION) on its Seed II financing round in the amount of 2.3 million Euro. HEUKING had already advised EVERSION on its Seed I financing round in January 2025.

The family office Kammerer Holding and the venture capital fund of Kreissparkasse Biberach led the round. In addition, other well-known VCs, family offices, existing investors, and business angels participated in the financing round.

EVERSION was founded in Konstanz in 2023 and pursues the mission of offering people with musculoskeletal conditions a data-driven, transparent, and sustainable solution. The company develops smart insoles that don't simply support or cushion the foot, but actively and specifically correct improper weight distribution.

Before the custom insole is manufactured, sensor insoles work together with a smartphone app to analyze the user's movement patterns over a two-week period. A biomechanical 3D model uses this data to create a personal loading profile, on the basis of which the so-called 0° insole is manufactured. This is designed to bring the foot back into a natural position while preserving its mobility.

Following CE certification, market entry, and reimbursement eligibility from statutory health insurers, EVERSION already counts more than 1,500 customers.

With the fresh capital, EVERSION intends in particular to expand sales and marketing, grow its partner network, and further accelerate the adoption of its medical solution.

Counsel to EVERSION Technologies GmbH
HEUKING:
Ariane Neubauer (Venture Capital), Berlin